Genetic mechanisms of co-emergence of INH-resistant Mycobacterium tuberculosis strains during the standard course of antituberculosis therapy
Microbiology Spectrum · 2024
DOI: 10.1128/spectrum.02133-23 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiology Spectrum, 2024. Verfasst von Ketema Tafess und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Applied Biology, School of Applied Natural Sciences, Adama Science and Technology University, Adama, Ethiopia. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Tuberculosis, Multidrug-Resistant. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: General Research Fund.
Abstract (Originalsprache)
The incidence of isoniazid (INH) resistant Mycobacterium tuberculosis is increasing globally. This study aimed to identify the molecular mechanisms behind the development of INH resistance in M. tuberculosis strains collected from the same patients during the standard course of treatment. Three M. tuberculosis strains were collected from a patient before and during antituberculosis (anti-TB) therapy. The strains were characterized using phenotypic drug susceptibility tests, Mycobacterial Interspersed Repeated Unit-Variable-Number Tandem Repeats (MIRU-VNTR), and whole-genome sequencing (WGS) to identify mutations associated with INH resistance. To validate the role of the novel mutations in INH resistance, the mutated katG genes were electroporated into a KatG-deleted M. tuberculosis strain (GA03). Three-dimensional structures of mutated KatG were modeled to predict their impact on INH binding. The pre-treatment strain was susceptible to INH. However, two INH-resistant strains were isolated from the patient after anti-TB therapy. MIRU-VNTR and WGS revealed that the three strains were clonally identical. A missense mutation (P232L) and a nonsense mutation (Q461Stop) were identified in the katG of the two post-treatment strains, respectively. Transformation experiments showed that katG of the pre-treatment strain restored INH susceptibility in GA03, whereas the mutated katG genes from the post-treatment strains rendered negative catalase activity and INH resistance. The protein model indicated that P232L reduced INH-KatG binding affinity while Q461Stop truncated gene transcription. Our results showed that the two katG mutations, P232L and Q461Stop, accounted for the co-emergence of INH-resistant clones during anti-TB therapy. The inclusion of these mutations in the design of molecular assays could increase the diagnostic performance. IMPORTANCE The evolution of drug-resistant strains of Mycobacterium tuberculosis within the lung lesions of a patient has a detrimental impact on treatment outcomes. This is particularly concerning for isoniazid (INH), which is the most potent first-line antimycobacterial drug. However, the precise genetic factors responsible for drug resistance in patients have not been fully elucidated, with approximately 15% of INH-resistant strains harboring unknown genetic factors. This raises concerns about the emergence of drug-resistant clones within patients, further contributing to the global epidemic of resistance. In this study, we revealed the presence of two novel katG mutations, which emerged independently due to the stress exerted by antituberculosis (anti-TB) treatment on a parental strain. Importantly, we experimentally demonstrated the functional significance of both mutations in conferring resistance to INH. Overall, this research sheds light on the genetic mechanisms underlying the evolution of INH resistance within patients and provides valuable insights for improving diagnostic performance by targeting specific mutations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Applied Biology, School of Applied Natural Sciences, Adama Science and Technology University, Adama, Ethiopia.
- Institute of Pharmaceutical Sciences, Adama Science and Technology University, Adama, Ethiopia.
- Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Kowloon, Hong Kong SAR, China.
- Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR, China.
- Department of Biomedical Sciences, Jockey Club College of Veterinary Medicine and Life Sciences, City University of Hong Kong, Hong Kong, China.
ORCID-Profile: Terrence Chi-Kwong Lau, Gilman Kit-Hang Siu
Förderung
- General Research Fund
Zitieren
APA
Tafess, K., Ng, T. T. L., Tam, K. K. G., Leung, K. S. S., Leung, J. S. L., Lee, L. K., Lao, H. Y., Chan, C. T. M., Yam, W. C., Wong, S. S. Y., Lau, T. C. K., & Siu, G. K. H. (2024). Genetic mechanisms of co-emergence of INH-resistant Mycobacterium tuberculosis strains during the standard course of antituberculosis therapy. Microbiology Spectrum. https://doi.org/10.1128/spectrum.02133-23
Vancouver
Tafess K, Ng TTL, Tam KKG, Leung KSS, Leung JSL, Lee LK, et al. Genetic mechanisms of co-emergence of INH-resistant Mycobacterium tuberculosis strains during the standard course of antituberculosis therapy. Microbiology Spectrum. 2024. doi:10.1128/spectrum.02133-23
BibTeX
@article{Tafess2024,
author = {Tafess, Ketema and Ng, Timothy Ting-Leung and Tam, Kingsley King-Gee and Leung, Kenneth Siu-Sing and Leung, Jake Siu-Lun and Lee, Lam-Kwong and Lao, Hiu Yin and Chan, Chloe Toi-Mei and Yam, Wing-Cheong and Wong, Samson Sai Yin and Lau, Terrence Chi-Kwong and Siu, Gilman Kit-Hang},
title = {Genetic mechanisms of co-emergence of INH-resistant Mycobacterium tuberculosis strains during the standard course of antituberculosis therapy},
journal = {Microbiology Spectrum},
year = {2024},
doi = {10.1128/spectrum.02133-23}
}
EUVIMED